The global leader in USAN/INN naming, partnering on 76% of USAN and 78% of INN drug name approvals!

436
Healthcare Clients
3537
Total Healthcare Names
614
Oncology Names
CLIENTNAMECATEGORY
PHARMACYCLICSabexinostatOncology
ASTRAZENECAacalabrutinibOncology
ACERTA PHARMAacalabrutinibOncology
GILEADacalisibOncology
AMGENacapatamabOncology
ACTINIUMactinium (225ac) lintuzumab satetraxetanOncology
ASTRAZENECAadavosertibOncology
ADAPTIMMUNEafamitresgene autoleucelOncology
ADAPTIMMUNEafamitresgene autoleucelOncology
PFIZERagatolimodOncology
SHIONOGI PHARMAalicdamotideOncology
TAKEDAalisertibOncology
GILEADalobresibOncology
FIVE PRIME THERAPEUTICSalsevalimabOncology
CHONG KUN DANGalteminostatOncology
BRISTOL MYERS SQUIBBalvespimycinOncology
BRISTOL MYERS SQUIBBalvespimycin hydrochlorideOncology
SANOFIamcenestrantOncology
SANOFIamcenestrantOncology
JANSSENamivantamabOncology
BRISTOL MYERS SQUIBBamrubicin hydrochlorideOncology
GILEADandecaliximabOncology
JANSSENapalutamideOncology
BAYERaprutumabOncology
BAYERaprutumab ixadotinOncology
ISOFOLarfolitixorinOncology
BIOSIGHTaspacytarabineOncology
GLAXOSMITHKLINEastuprotimut-rOncology
SHIONOGI PHARMAasudemotideOncology
GENENTECHatezolizumabOncology
GENENTECHautogene cevumeranOncology
GENENTECHautogene cevumeranOncology
BASILEA PHARMACEUTICAavanbulinOncology
BLUEPRINT MEDICINESavapritinibOncology
NEKTARavipendekin pegolOncology
BEYONDBIOavotaciclibOncology
ADVAXISaxalimogene filolisbacOncology
SYNDAXaxatilimabOncology
ABBVIEazintuxizumabOncology
ABBVIEazintuxizumab vedotinOncology
MERCK & CO.baloramotideOncology
ISU ABXISbarecetamabOncology
ARIVIVEbatiraxceptOncology
GlaxoSmithKlinebelantamabOncology
GlaxoSmithKlinebelantamab mafodotinOncology
SPECTRUM PHARMACEUTICALSbelinostatOncology
GLAXOSMITHKLINEbelizatinibOncology
HANMI PHARMACEUTICALSbelvarafenibOncology
MERCK & CO.belzutifanOncology
FIVE PRIME THERAPEUTICSbemarituzumabOncology
BERGEN BIObemcentinibOncology
NEKTARbempegaldesleukinOncology
BioInvent InternationalbersanlimabOncology
VERTEX PHARMACEUTICALSberzosertibOncology
AMGENbevacizumab betaOncology
ASTRAZENECAbicalutamideOncology
PIQURbimiralisibOncology
Inoviobizalimogene ralaplasmidOncology
MEDIMMUNEblinatumomabOncology
MEREO BIOPHARMbrontictuzumabOncology
ABBVIEbudigalimabOncology
FIVE PRIME THERAPEUTICScabiralizumabOncology
EXELIXIScabozantinibOncology
MERCK & CO.cadalimogene ixalentivecOncology
ADC THERAPEUTICScamidanlumabOncology
ADC THERAPEUTICScamidanlumab tesirineOncology
MONOPARcamsirubicinOncology
TAKARA BIOcanerpaturevOncology
IMMUNOGENcantuzumab ravtansineOncology
ASTRAZENECAcapivasertibOncology
ADVAXIScapolimogene apralisbacOncology
JOHNSON & JOHNSONcarlumabOncology
TRACON PHARMACEUTICALScarotuximabOncology
AstexcedazuridineOncology
ABBVIEcedirogantOncology
ASTRAZENECAceralasertibOncology
ALEXION PHARMACEUTICALScerdulatinibOncology
JanssencetrelimabOncology
GENENTECHcevostamabOncology
JANSSENciltacabtagene autoleucelOncology
PIERIS PHARMACEUTICALScinrebafusp alfaOncology
LYCERAcintirorgonOncology
SAMUMEDcirtuvivintOncology
GENENTECHcobimetinibOncology
BAYERcopanlisibOncology
GENORBIOcoprelotamabOncology
CHECKPOINT THERAPEUTICScosibelimabOncology
CHINOOK THERAPEUTICSdamistimagene matitucelOncology
ASTRAZENECAdanvatirsenOncology
JANSSENdaratumumabOncology
BAYERdarolutamideOncology
IDEAYA BIOSCIENCESdarovasertibOncology
DAIICHI-SANKYOdatopotamabOncology
DAIICHI-SANKYOdatopotamab deruxtecanOncology
CERULEANdavamotecan pegadexamerOncology
MEREO BIOPHARMdemcizumabOncology
NANOCARRIERdemplatin pegraglumerOncology
SEATTLE GENETICSdenintuzumab mafodotinOncology
ABBVIEdepatuxizumabOncology
ABBVIEdepatuxizumab mafodotinOncology
ARQULEderazantinibOncology
ARQULEderazantinib hydrochlorideOncology
RAFAEL PHARMACEUTICALSdevimistatOncology
APOTEXdocetaxelOncology
CANTEX PHARMACEUTICALSdociparstatOncology
NOVARTISdovitinibOncology
NOVARTISdovitinib lactateOncology
GENENTECHdulanerminOncology
GENENTECHduligotuzumabOncology
JANSSENduvortuxizumabOncology
MEREO BIOPHARMefaprinermin alfaOncology
MEDIMMUNEefgivanermin alfaOncology
Genexineefineptakin alfaOncology
ABBVIEeftozanermin alfaOncology
RADIUS HEALTHelacestrantOncology
SYNTA PHARMACEUTICALSelesclomolOncology
ABBVIEelotuzumabOncology
ONCOTHERAPY SCIENCEelpamotideOncology
PFIZERelranatamabOncology
AMGENeluvixtamabOncology
AMGENemerfetamabOncology
AGIOSenasidenibOncology
ABBOTT LABORATORIESenavatuzumabOncology
GLAXOSMITHKLINEencelimabOncology
ATHENEXencequidarOncology
SEATTLE GENETICSenfortumab vedotinOncology
CHINOOK THERAPEUTICSenistimagene setitucelOncology
XCOVERYensartinibOncology
NEOGENIX ONCOLOGYensituximabOncology
GILEADentospletinibOncology
IGNYTAentrectinibOncology
PFIZERenzalutamideOncology
SHIONOGI PHARMAepertinibOncology
APREAeprenetapoptOncology
MEDIMMUNEetaracizumabOncology
AMGENetevritamabOncology
OnxeoetidaligideOncology
MEREO BIOPHARMetigilimabOncology
NEKTARetirinotecan pegolOncology
NEKTARetirinotecan pegol tetrahydrochlorideOncology
NEKTARetirinotecan pegol tetratriflutateOncology
EMD SERONOevobrutinibOncology
SANOFIfedratinibOncology
GLAXOSMITHKLINEfeladilimabOncology
STEMLINE THERAPEUTICSfelezonexorOncology
MORPHOSYSfelzartamabOncology
NIPPON KAYAKUfirtecan peglumerOncology
BLUEPRINT MEDICINESfisogatinibOncology
SIEMENSflortanidazole (18f)Oncology
SIEMENSflotegatide (18f)Oncology
BLUE EARTH DIAGNOSTICSflotufolastat (18f)Oncology
MAST THERAPEUTICSfolitixorinOncology
MAST THERAPEUTICSfolitixorin calciumOncology
OXIGENEfosbretabulinOncology
OXIGENEfosbretabulin disodiumOncology
OXIGENEfosbretabulin tromethamineOncology
BIONOVUS LIFE SCIENCESfosciclopiroxOncology
NUCANAfosgemcitabine palabenamideOncology
NUCANAfosifloxuridine nafalbenamideOncology
TAIRXfoslinanibOncology
BEIGENEgarivulimabOncology
GLYCOTOPEgatipotuzumabOncology
SANOFI GENZYMEgatralimabOncology
PFIZERgemtuzumab ozogamicinOncology
GENORBIOgeptanolimabOncology
ABBVIEgiloralimabOncology
ASTELLASgilteritinibOncology
MIRATI THERAPEUTICSglesatinibOncology
ASTEXguadecitabineOncology
PHARMACYCLICSibrutinibOncology
GILEADidelalisibOncology
ABBVIEilorasertibOncology
TAKEDAimalumabOncology
ROCHEimgatuzumabOncology
PHOSPLATIN THERAPEUTICSimifoplatinOncology
TAKEDAindusatumabOncology
TAKEDAindusatumab vedotinOncology
LUNDBECKingenol disoxateOncology
BIPARiniparibOncology
BIOCANCELL THERAPEUTICSinodiftagene vixteplasmidOncology
JOHNSON & JOHNSONintetumumabOncology
ACTINIUMiodine (131i) apamistamabOncology
MEREO BIOPHARMipafriceptOncology
GENENTECHipatasertibOncology
SANOFIisatuximabOncology
AGIOSivosidenibOncology
TAKEDAixazomibOncology
SEATTLE GENETICSladiratuzumabOncology
SEATTLE GENETICSladiratuzumab vedotinOncology
MERCK & CO.lapretolimodOncology
IMMUNOGENlaprituximabOncology
IMMUNOGENlaprituximab emtansineOncology
DENDREONlapuleucel-tOncology
VIONlaromustineOncology
LOXO ONCOLOGYlarotrectinibOncology
ONCOTHERAPY SCIENCElatromotideOncology
JANSSENlazertinibOncology
MOLOGENlefitolimodOncology
ADAPTIMMUNEletetresgene autoleucelOncology
YM BIOSCIENCESlexibulinOncology
IOVANCE BIOTHERAPEUTICSlifileucelOncology
BEIGENElifirafenibOncology
ABBVIElinifanibOncology
OSI PHARMACEUTICALSlinsitinibOncology
CONSTELLATIONlirametostatOncology
BASILEA PHARMACEUTICAlisavanbulinOncology
JW THERAPEUTICSlisocabtagene maraleucelOncology
ADC THERAPEUTICSloncastuximabOncology
ADC THERAPEUTICSloncastuximab tesirineOncology
JANSSENlorpucitinibOncology
APEIRONlorukafusp alfaOncology
IMMUNOGENlorvotuzumab mertansineOncology
NOVARTISlucatumumabOncology
GILEADmagrolimabOncology
Inoviomavilimogene ralaplasmidOncology
X4mavorixaforOncology
ONCOPEPTIDESmelphalan flufenamideOncology
SYROSmevociclibOncology
DAIICHI-SANKYOmilademetanOncology
ADC THERAPEUTICSmipasetamabOncology
ADC THERAPEUTICSmipasetamab uzoptirineOncology
TAKARA BIOmipetresgene autoleucelOncology
INSPYR TherapeuticsmipsagarginOncology
ARQULEmiransertibOncology
IMMUNOGENmirvetuximab soravtansineOncology
ABBVIEmirzotamabOncology
ABBVIEmirzotamab clezutoclaxOncology
JANSSENmitazalimabOncology
TAKEDAmivavotinibOncology
TAKEDAmobocertinibOncology
MIRATI THERAPEUTICSmocetinostatOncology
MIRATI THERAPEUTICSmocetinostat dihydrobromideOncology
GLAXOSMITHKLINEmolibresibOncology
EnzyChemmosedipimodOncology
GENENTECHmosunetuzumabOncology
BIOLINE RXmotixafortideOncology
MEDIMMUNEmoxetumomab pasudotoxOncology
AMGENmurizatoclaxOncology
GAMAMABSmurlentamabOncology
IMMUNOGENnaratuximab emtansineOncology
MEREO BIOPHARMnavicixizumabOncology
MEREO BIOPHARMnavicixizumabOncology
ABBVIEnavitoclaxOncology
ALKERMESnemvaleukin alfaOncology
AUTOLUSobecabtagene autoleucelOncology
BEIGENEociperlimabOncology
CHECKPOINT THERAPEUTICSolafertinibOncology
ADAPTIMMUNEolitresgene autoleucelOncology
HANMI PHARMACEUTICALSolmutinibOncology
ASCENTAGE PHARMAolverembatinibOncology
TEVA PHARMACEUTICALS INDUSTRIESomacetaxine mepesuccinateOncology
GLAXOSMITHKLINEomipalisibOncology
JANSSENonametostatOncology
BRISTOL MYERS SQUIBBonatasertibOncology
BRISTOL MYERS SQUIBBonatasertibOncology
JanssenonvatilimabOncology
JANSSENopolimogene capmilisbacOncology
AMGENoprozomibOncology
TAKEDAorteronelOncology
BRISTOL MYERS SQUIBBorvacabtagene autoleucelOncology
AMGENpacanalotamabOncology
GERONpaclitaxel trevatideOncology
CYTOMX THERAPEUTICSpacmilimabOncology
BEIGENEpamiparibOncology
DAIICHI-SANKYOpatritumabOncology
AMGENpavurutamabOncology
JAZZ PHARMACEUTICALSpegcrisantaspaseOncology
AVELAS BIOSCIENCESpegloprastideOncology
HALOZYME THERAPEUTICSpegvorhyaluronidase alfaOncology
CONSTELLATIONpelabresibOncology
ASCENTAGE PHARMApelcitoclaxOncology
MERCK & CO.pembrolizumabOncology
IncytepemigatinibOncology
JANSSENpemlimogene merolisbacOncology
GLAXOSMITHKLINEpemrametostatOncology
SILLAJENpexastimogene devacirepvecOncology
DAIICHI-SANKYOpexidartinibOncology
SANOFIpilaralisibOncology
JOUNCEpimivalimabOncology
GENENTECHpinatuzumab vedotinOncology
EPIZYMEpinometostatOncology
GENENTECHpolatuzumab vedotinOncology
BRISTOL MYERS SQUIBBpomalidomideOncology
ARIADponatinibOncology
ARIADponatinib hydrochlorideOncology
HANMI PHARMACEUTICALSposeltinibOncology
ONCOTHERAPY SCIENCEpradimotideOncology
BLUEPRINT MEDICINESpralsetinibOncology
CYTOMX THERAPEUTICSpraluzatamabOncology
CYTOMX THERAPEUTICSpraluzatamab ravtansineOncology
BIO-PATH HOLDINGSprexigebersenOncology
JOHNSON & JOHNSONquisinostatOncology
BAYERradretumabOncology
BAYERrefametinibOncology
JW PHARMACEUTICALrelmacabtagene autoleucelOncology
4SCresminostatOncology
ABBVIErevdofilimabOncology
BETA PHARMArezivertinibOncology
ACETYLONricolinostatOncology
BELLICUM PHARMACEUTICALSrimiducidOncology
LSK BIOPHARMArivoceranibOncology
ABBVIErizankizumabOncology
CLOVIS ONCOLOGYrociletinibOncology
ABBVIErolinsatamabOncology
ABBVIErolinsatamab talirineOncology
BAYERroniciclibOncology
SYNTA PHARMACEUTICALSrosabulinOncology
MEREO BIOPHARMrosmantuzumabOncology
TELIX PHARMACEUTICALSrosopatamabOncology
TELIX PHARMACEUTICALSrosopatamab tetraxetanOncology
ABBVIErovalpituzumabOncology
ABBVIErovalpituzumab tesirineOncology
LYTIX BIOPHARMAruxotemitideOncology
ABBVIEsamrotamabOncology
ABBVIEsamrotamab vedotinOncology
TAKEDAsapanisertibOncology
IPSEN BIOPHARM LTDsatoreotide tetraxetanOncology
OCTREOPHARMsatoreotide trizoxetanOncology
ASTRAZENECAsavolitinibOncology
SalariusseclidemstatOncology
KARYOPHARMselinexorOncology
LOXO ONCOLOGYselitrectinibOncology
LOXO ONCOLOGYselpercatinibOncology
JANSSENseltorexantOncology
ASTRAZENECAselumetinibOncology
ASTRAZENECAselumetinib sulfateOncology
TAKEDAserabelisibOncology
ABBVIEserclutamabOncology
ABBVIEserclutamab talirineOncology
JOHNSON & JOHNSONserdemetanOncology
SANOFIseribantumabOncology
INNOCRIN PHARMACEUTICALSseviteronelOncology
JOHNSON & JOHNSONsiltuximabOncology
GILEADsimtuzumabOncology
TAKEDAsimurosertibOncology
DENDREONsipuleucel-tOncology
MIRATI THERAPEUTICSsitravatinibOncology
SEATTLE GENETICSsonolisibOncology
BAYERsorafenibOncology
AMGENsotorasibOncology
AILERON THERAPEUTICSsulanemadlinOncology
ONCOTHERAPYSCIENCEtabituximabOncology
ONCOTHERAPYSCIENCEtabituximab barzuxetanOncology
MORPHOSYStafasitamabOncology
JANSSENtalacotuzumabOncology
PFIZERtalazoparibOncology
ANHEART THERAPEUTICStaletrectinibOncology
JOHNSON & JOHNSONtalmapimodOncology
JANSSENtalquetamabOncology
ABBVIEtamrintamabOncology
ABBVIEtamrintamab pamozirineabOncology
BRISTOL MYERS SQUIBBtanespimycinOncology
AMGENtapotoclaxOncology
MEREO BIOPHARMtarextumabOncology
AMGENtarlatamabOncology
THRESHOLD PHARMACEUTICALStarloxotinib bromideOncology
DNATRIX, Inc.tasadenoturevOncology
GENENTECHtaselisibOncology
OncoSectavokinogene telseplasmidOncology
EPIZYMEtazemetostatOncology
TAKARA BIOtebrocabtagene autoleucelOncology
JANSSENteclistamabOncology
BetaCattegavivintOncology
CALITHERAtelaglenastatOncology
GLENMARK PHARMACEUTICALStelazorlimabOncology
ABBVIEtelisotuzumabOncology
ABBVIEtelisotuzumab vedotinOncology
ASTRAZENECAtelratolimodOncology
ERIMOS PHARMACEUTICALSterameprocolOncology
AURINIAterameprocolOncology
AFFIBODYtezatabep matraxetanOncology
GILEADtilpisertibOncology
IDERA PHARMACEUTICALStilsotolimodOncology
BERGEN BIOtilvestamabOncology
GLYCOTOPEtimigutuzumabOncology
MUNDIPHARMAtinostamustineOncology
GILEADtirabrutinibOncology
GENENTECHtiragolumabOncology
ATHENEXtirbanibulinOncology
GENEXINEtirvalimogene teraplasmidOncology
NOVARTIStisagenlecleucelOncology
BEIGENEtislelizumabOncology
DAIICHI-SANKYOtivantinibOncology
EffectortomivosertibOncology
GLYCOTOPEtomuzotuximabOncology
BLAZE BIOSCIENCEtozuleristideOncology
AMGENtrebananibOncology
SHIONOGI PHARMAtrempamotideOncology
SEATTLE GENETICStucatinibOncology
BIOMED VALLEYulixertinibOncology
GLAXOSMITHKLINEuprosertibOncology
SURFACE ONCOLOGYurabrelimabOncology
BRISTOL MYERS SQUIBBvadacabtagene leraleucelOncology
BRISTOL MYERS SQUIBBvadacabtagene leraleucelOncology
SEATTLE GENETICSvadastuximabOncology
SEATTLE GENETICSvadastuximab talirineOncology
CHONG KUN DANGvalecobulinOncology
MEREO BIOPHARMvantictumabOncology
SUNESIS PHARMACEUTICALSvecabrutinibOncology
INTREXONveledimexOncology
ABBVIEveliparibOncology
ABBVIEvenetoclaxOncology
MYRIADverubulinOncology
GILEADvesatolimodOncology
ARQULEvevorisertibOncology
CELLIDvibapapogene autoleucelOncology
DECIPHERA PHARMACEUTICALSvimseltinibOncology
SPARCvodobatinibOncology
JouncevopratelimabOncology
AGIOSvorasidenibOncology
AGIOSvorasidenib citrateOncology
TYROGENEXvorolanibOncology
SEATTLE GENETICSvorsetuzumab mafodotinOncology
SUNESIS PHARMACEUTICALSvosaroxinOncology
RADIUS HEALTHvosilasarmOncology
SANOFIvoxtalisibOncology
IPSEN BIOPHARM LTDzalsenertant tetraxetanOncology
MEI PHARMAzandelisibOncology
ZYMEWORKSzanidatamabOncology
ZYMEWORKSzanidatamab zovodotinOncology
BEIGENEzanubrutinibOncology
GLAXOSMITHKLINEzastumotideOncology
MARKER THERAPEUTICSzedenoleucelOncology
MERUSzenocutuzumabOncology
ARCUSzimberelimabOncology
ASTELLASzolbetuximabOncology
EFFECTORzotatifinOncology